India’s Dengue Fight: Vaccine Rollout, New Treatments, and Mosquito Control Ahead of Monsoon

India is advancing toward broader access to dengue prevention and treatment as health authorities evaluate new vaccine options and prepare for seasonal outbreaks ahead of the monsoon. With dengue transmission patterns shifting due to climate change and urbanization, officials are prioritizing both vaccine rollout and innovative vector control measures to reduce the disease burden.

The Drugs Controller General of India has recommended approval for Takeda’s dengue vaccine, Qdenga, for use in individuals aged 4 to 60 years. The recommendation, issued by an expert panel under the Central Drugs Standard Control Organisation, is conditional upon the company conducting a post-marketing study within six months to assess safety and effectiveness in the Indian population. If cleared, the vaccine would be administered to a wide age group and could become a key tool in reducing severe dengue cases.

Qdenga is a live-attenuated, tetravalent vaccine designed to protect against all four strains of the dengue virus. It has already received regulatory approval in more than 40 countries. In India, the vaccine is being evaluated under a “Make in India” initiative, with plans for local manufacturing to improve accessibility and affordability. Health experts note that while the vaccine offers significant protection, it is not a standalone solution and must be complemented by vector control and public awareness efforts.

In parallel, Indian cities are deploying new strategies to curb mosquito breeding ahead of the monsoon season. Mumbai’s municipal corporation has launched the Muvvi trap, an eco-friendly device that targets the breeding cycle of Aedes mosquitoes. The trap attracts female mosquitoes, which lay eggs in treated water; an insecticide then destroys the eggs before they can hatch. Developed under the Society for Mumbai Incubation Lab to Entrepreneurship (Smile), the initiative represents a shift from conventional killing methods to interrupting reproduction at the source.

Public health officials emphasize that climate change is expanding the geographic range and lengthening the transmission season for dengue. Warmer temperatures, erratic rainfall, and prolonged humidity create favorable breeding conditions for Aedes mosquitoes, leading to outbreaks in areas previously less affected. Urbanization and water stagnation in peri-urban zones have further contributed to rising case numbers, making early intervention critical.

Experts urge timely action to address gaps in dengue care, particularly before the monsoon surge. While vaccines and traps offer promise, equitable access to diagnostics and timely medical care remains a challenge in many regions. Strengthening surveillance, training healthcare workers, and ensuring availability of supportive care are seen as essential components of a comprehensive response.

As India moves closer to securing its first widely usable dengue vaccine, health authorities stress that prevention must be multi-pronged. Combining immunization, environmental management, and clinical preparedness offers the best chance to reduce the impact of dengue in the coming years.